BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 35199580)

  • 1. Anticipated efficiencies, real costs: Medicaid managed care organizations and the pharmacy benefit.
    Bendicksen L; Kesselheim AS
    J Manag Care Spec Pharm; 2022 Mar; 28(3):354-361. PubMed ID: 35199580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences Between Managed Care and Fee-for-Service Medicaid in the Use of Generics for High-Rebate Drugs: The Cases of Insulin Glargine and Glatiramer.
    Hernandez I; Gellad WF
    J Manag Care Spec Pharm; 2020 Feb; 26(2):154-159. PubMed ID: 32011961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AMCP Partnership Forum: Advancing Value-Based Contracting.
    J Manag Care Spec Pharm; 2017 Nov; 23(11):1096-1102. PubMed ID: 29083973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opinions regarding the Academy of Managed Care Pharmacy dossier submission guidelines: results of a small survey of managed care organizations and pharmaceutical manufacturers.
    Nichol MB; Knight TK; Epstein J; Honda DH; Tretiak R
    J Manag Care Pharm; 2007 May; 13(4):360-71. PubMed ID: 17506602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evolution of the TRICARE Pharmacy Benefit: A Decade of Change.
    Lugo AM; Allerman AA; Trice SK
    J Manag Care Spec Pharm; 2019 Nov; 25(11):1195-1200. PubMed ID: 31663455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Managed approaches to multiple sclerosis in special populations.
    Sperandeo K; Nogrady L; Moreo K; Prostko CR
    J Manag Care Pharm; 2011; 17(9 Suppl C):S1-19; quiz S20-1. PubMed ID: 22107156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Understanding Payer Perspectives on Value in the Use of Pharmaceuticals in the United States.
    Brogan AP; Hogue SL; Vekaria RM; Reynolds I; Coukell A
    J Manag Care Spec Pharm; 2019 Dec; 25(12):1319-1327. PubMed ID: 31778613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Milestones in managed care pharmacy.
    Cantrell S; Reilly C
    J Manag Care Spec Pharm; 2020 Nov; 26(11):1379-1383. PubMed ID: 33119449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Current Status of Outcomes-Based Contracting for Manufacturers and Payers: An AMCP Membership Survey.
    Duhig AM; Saha S; Smith S; Kaufman S; Hughes J
    J Manag Care Spec Pharm; 2018 May; 24(5):410-415. PubMed ID: 29337604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacy benefit manager reform within Medicaid Managed Care: The pursuit of a model that preserves the intent of the 340B program.
    Almeter PJ; Butler WR; Reynolds JW; Duckworth DL; Labuhn JA; Birdwhistell MD
    Am J Health Syst Pharm; 2022 Sep; 79(18):1607-1611. PubMed ID: 35020794
    [No Abstract]   [Full Text] [Related]  

  • 11. The affordable care ACT on loyalty programs for federal beneficiaries.
    Piacentino JJ; Williams KG
    J Pharm Pract; 2014 Feb; 27(1):106-8. PubMed ID: 24375998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Primer for Managed Care Residents: How to Conduct Research Using Live Medical and Pharmacy Claims Data.
    Hung A; Gedey R; Groeneweg M; Jay M
    J Manag Care Spec Pharm; 2019 May; 25(5):538-543. PubMed ID: 31039066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medicaid managed care reimbursement for HIV and its implications for access to care.
    Conviser R; Murray M; Lau D
    Am J Manag Care; 2000 Sep; 6(9):990-9. PubMed ID: 11184069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medicaid Utilization and Spending among Homeless Adults in New Jersey: Implications for Medicaid-Funded Tenancy Support Services.
    Cantor JC; Chakravarty S; Nova J; Kelly T; Delia D; Tiderington E; Brown RW
    Milbank Q; 2020 Mar; 98(1):106-130. PubMed ID: 31967354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prior Authorization and Utilization Management Concepts in Managed Care Pharmacy.
    2018-2019 Academy of Managed Care Pharmacy Professional Practice Committee
    J Manag Care Spec Pharm; 2019 Jun; 25(6):641-644. PubMed ID: 30977701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of managed care on pharmacy practice.
    Schafermeyer KW
    Pharm Pract Manag Q; 2000 Jan; 19(4):99-116. PubMed ID: 10787569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Managing drug costs: the perception of managed care pharmacy directors.
    Litton LM; Sisk FA; Akins ME
    Am J Manag Care; 2000 Jul; 6(7):805-14. PubMed ID: 11067377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Iowa community pharmacies' experiences with Medicaid managed care.
    Urmie JM; Murry LT; Deng H; Doucette WR
    J Am Pharm Assoc (2003); 2020; 60(4):624-630. PubMed ID: 31901442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coverage and Prior Authorization Policies for Medications for Opioid Use Disorder in Medicaid Managed Care.
    Abraham AJ; Andrews CM; Harris SJ; Westlake MM; Grogan CM
    JAMA Health Forum; 2022 Nov; 3(11):e224001. PubMed ID: 36331441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improving state Medicaid contracts and plan practices for children with special needs.
    Fox HB; McManus MA
    Future Child; 1998; 8(2):105-18. PubMed ID: 9782653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.